Ranbaxy to establish marketing alliances via investment

16 July 2006

Indian drugmaker Ranbaxy Laboratories says it will acquire stakes in two as yet unidentified companies, in order to establish marketing alliances with those firms. Ranbaxy added that its aim is to use a worldwide marketing network to source products through collaborations in regions where it does not have a significant presence. The firm added that it has also acquired a 10% holding in fellow Indian company Zenotech and has agreed a marketing venture to commercialize the latter's injectable oncology products for international markets.

This article is accessible to registered users, to continue reading please register for free.  A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Login to your account

Become a subscriber

 

£820

Or £77 per month

Subscribe Now
  • Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
  • Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
  • Daily roundup of key events in pharma and biotech.
  • Monthly in-depth briefings on Boardroom appointments and M&A news.
  • Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK



Companies featured in this story

More ones to watch >


Today's issue

Company Spotlight